Valdenegro 4337, C1430EFA Cdad. Autónoma de Buenos Aires, Argentina
Select an option
I am a doctor
I am a sponsor
Our team
Medical staff
Fernando Galanternik
Open studies
Bladder Cancer
Treatment Combination of Durvalumab, Tremelimumab and Enfortumab Vedotin or Durvalumab and Enfortumab Vedotin in Patients With Muscle Invasive Bladder Cancer Ineligible to Cisplatin or Who Refuse Cisplatin - VOLGA - AstraZenecaSee more
